Literature DB >> 23825080

20-HETE induces remodeling of renal resistance arteries independent of blood pressure elevation in hypertension.

Yan Ding1, Cheng-Chia Wu, Victor Garcia, Irina Dimitrova, Adam Weidenhammer, Gregory Joseph, Frank Zhang, Vijay L Manthati, John R Falck, Jorge H Capdevila, Michal L Schwartzman.   

Abstract

20-Hydroxyeicosatetraenoic acid (20-HETE) is a cytochrome P-450 (Cyp)-derived arachidonic acid metabolite that has been shown to increase smooth muscle contractions and proliferation, stimulate endothelial dysfunction and activation, and promote hypertension. We examined if 20-HETE contributes to microvascular remodeling in hypertension. In Sprague-Dawley rats, administration of the 20-HETE biosynthesis inhibitor HET0016 or the 20-HETE antagonist N-20-hydroxyeicosa-6(Z),15(Z)-dienoic acid (20-HEDE) prevented 5α-dihydrotestosterone (DHT)-induced increases in blood pressure as well as abrogated DHT-induced increases in the media-to-lumen ratio (M/L), media thickness, and collagen IV deposition in renal interlobar arteries. Reserpine prevented blood pressure elevation in DHT-treated rats but did not affect microvascular remodeling (M/L, media thickness, and collagen deposition); under these conditions, treatment with the 20-HETE antagonist attenuated microvascular remodeling, suggesting that 20-HETE contributes to DHT-induced vascular remodeling independent of blood pressure elevation. In Cyp4a14(-/-) mice, which display androgen-driven and 20-HETE-dependent hypertension, treatment with the 20-HETE antagonist abolished remodeling of renal resistance arteries measured as media thickness (24 ± 1 vs. 15 ± 1 μm) and M/L (0.29 ± 0.03 vs. 0.17 ± 0.01). Moreover, in Cyp4a12 transgenic mice in which the expression of Cyp4a12-20-HETE synthase is driven by a tetracycline-sensitive promoter, treatment with doxycycline resulted in blood pressure elevation (140 ± 4 vs. 92 ± 5 mmHg) and a significant increase in remodeling of renal resistance arteries (media thickness: 23 ± 1 vs. 16 ± 1 μm; M/L: 0.39 ± 0.04 vs. 0.23 ± 0.02); these increases were abrogated by cotreatment with 20-HEDE. This study demonstrated that 20-HETE is a key regulator of microvascular remodeling in hypertension; its effect is independent of blood pressure elevation and androgen levels.

Entities:  

Keywords:  20-hydroxyeicosatetraenoic acid; androgen; blood pressure; cytochrome P-450 4A

Mesh:

Substances:

Year:  2013        PMID: 23825080      PMCID: PMC3761206          DOI: 10.1152/ajprenal.00292.2013

Source DB:  PubMed          Journal:  Am J Physiol Renal Physiol        ISSN: 1522-1466


  43 in total

1.  HET0016, a potent and selective inhibitor of 20-HETE synthesizing enzyme.

Authors:  N Miyata; K Taniguchi; T Seki; T Ishimoto; M Sato-Watanabe; Y Yasuda; M Doi; S Kametani; Y Tomishima; T Ueki; M Sato; K Kameo
Journal:  Br J Pharmacol       Date:  2001-06       Impact factor: 8.739

2.  Small GTP binding protein Ras contributes to norepinephrine-induced mitogenesis of vascular smooth muscle cells.

Authors:  M M Muthalif; M R Uddin; S Fatima; J H Parmentier; Z Khandekar; K U Malik
Journal:  Prostaglandins Other Lipid Mediat       Date:  2001-05       Impact factor: 3.072

Review 3.  From bedside to bench to bedside: role of renin-angiotensin-aldosterone system in remodeling of resistance arteries in hypertension.

Authors:  Ernesto L Schiffrin; Rhian M Touyz
Journal:  Am J Physiol Heart Circ Physiol       Date:  2004-08       Impact factor: 4.733

4.  Alterations in the regulation of androgen-sensitive Cyp 4a monooxygenases cause hypertension.

Authors:  V R Holla; F Adas; J D Imig; X Zhao; E Price; N Olsen; W J Kovacs; M A Magnuson; D S Keeney; M D Breyer; J R Falck; M R Waterman; J H Capdevila
Journal:  Proc Natl Acad Sci U S A       Date:  2001-04-24       Impact factor: 11.205

Review 5.  Regulation of mitogen-activated protein kinase signaling networks by G protein-coupled receptors.

Authors:  J S Gutkind
Journal:  Sci STKE       Date:  2000-07-11

Review 6.  Vascular remodeling in hypertension: roles of apoptosis, inflammation, and fibrosis.

Authors:  H D Intengan; E L Schiffrin
Journal:  Hypertension       Date:  2001-09       Impact factor: 10.190

7.  Cytochrome P-450 metabolites mediate norepinephrine-induced mitogenic signaling.

Authors:  M R Uddin; M M Muthalif; N A Karzoun; I F Benter; K U Malik
Journal:  Hypertension       Date:  1998-01       Impact factor: 10.190

8.  Angiotensin II releases 20-HETE from rat renal microvessels.

Authors:  K D Croft; J C McGiff; A Sanchez-Mendoza; M A Carroll
Journal:  Am J Physiol Renal Physiol       Date:  2000-09

9.  Androgen-mediated induction of the kidney arachidonate hydroxylases is associated with the development of hypertension.

Authors:  Kiyoshi Nakagawa; Jackleen S Marji; Michal L Schwartzman; Michael R Waterman; Jorge H Capdevila
Journal:  Am J Physiol Regul Integr Comp Physiol       Date:  2003-01-16       Impact factor: 3.619

Review 10.  20-HETE and blood pressure regulation: clinical implications.

Authors:  Cheng-Chia Wu; Tanush Gupta; Victor Garcia; Yan Ding; Michal L Schwartzman
Journal:  Cardiol Rev       Date:  2014 Jan-Feb       Impact factor: 2.644

View more
  15 in total

Review 1.  Cytochrome P450 and Lipoxygenase Metabolites on Renal Function.

Authors:  John D Imig; Md Abdul Hye Khan
Journal:  Compr Physiol       Date:  2015-12-15       Impact factor: 9.090

2.  20-HETE-induced mitochondrial superoxide production and inflammatory phenotype in vascular smooth muscle is prevented by glucose-6-phosphate dehydrogenase inhibition.

Authors:  Anand Lakhkar; Vidhi Dhagia; Sachindra Raj Joshi; Katherine Gotlinger; Dhara Patel; Dong Sun; Michael S Wolin; Michal L Schwartzman; Sachin A Gupte
Journal:  Am J Physiol Heart Circ Physiol       Date:  2016-02-26       Impact factor: 4.733

3.  The Blood Pressure-Lowering Effect of 20-HETE Blockade in Cyp4a14(-/-) Mice Is Associated with Natriuresis.

Authors:  Varunkumar Pandey; Victor Garcia; Ankit Gilani; Priyanka Mishra; Frank Fan Zhang; Mahesh P Paudyal; John R Falck; Alberto Nasjletti; Wen-Hui Wang; Michal Laniado Schwartzman
Journal:  J Pharmacol Exp Ther       Date:  2017-09-14       Impact factor: 4.030

4.  Intersection of the Roles of Cytochrome P450 Enzymes with Xenobiotic and Endogenous Substrates: Relevance to Toxicity and Drug Interactions.

Authors:  F Peter Guengerich
Journal:  Chem Res Toxicol       Date:  2016-08-11       Impact factor: 3.739

5.  Angiotensin II receptor blockade or deletion of vascular endothelial ACE does not prevent vascular dysfunction and remodeling in 20-HETE-dependent hypertension.

Authors:  Victor Garcia; Gregory Joseph; Brian Shkolnik; Yan Ding; Frank Fan Zhang; Katherine Gotlinger; John R Falck; Rambabu Dakarapu; Jorge H Capdevila; Kenneth E Bernstein; Michal Laniado Schwartzman
Journal:  Am J Physiol Regul Integr Comp Physiol       Date:  2015-04-29       Impact factor: 3.619

Review 6.  Vascular actions of 20-HETE.

Authors:  Samantha L Hoopes; Victor Garcia; Matthew L Edin; Michal L Schwartzman; Darryl C Zeldin
Journal:  Prostaglandins Other Lipid Mediat       Date:  2015-03-23       Impact factor: 3.072

7.  Elevated 20-HETE impairs coronary collateral growth in metabolic syndrome via endothelial dysfunction.

Authors:  Gregory Joseph; Amanda Soler; Rebecca Hutcheson; Ian Hunter; Chastity Bradford; Brenda Hutcheson; Katherine H Gotlinger; Houli Jiang; John R Falck; Spencer Proctor; Michal Laniado Schwartzman; Petra Rocic
Journal:  Am J Physiol Heart Circ Physiol       Date:  2016-12-23       Impact factor: 4.733

8.  Androgen-induced hypertension in angiotensinogen deficient mice: role of 20-HETE and EETS.

Authors:  Victor Garcia; Jennifer Cheng; Adam Weidenhammer; Yan Ding; Cheng-Chia Wu; Fan Zhang; Katherine Gotlinger; John R Falck; Michal L Schwartzman
Journal:  Prostaglandins Other Lipid Mediat       Date:  2014-12-17       Impact factor: 3.072

9.  20-HETE Signals Through G-Protein-Coupled Receptor GPR75 (Gq) to Affect Vascular Function and Trigger Hypertension.

Authors:  Victor Garcia; Ankit Gilani; Brian Shkolnik; Varunkumar Pandey; Frank Fan Zhang; Rambabu Dakarapu; Shyam K Gandham; N Rami Reddy; Joan P Graves; Artiom Gruzdev; Darryl C Zeldin; Jorge H Capdevila; John R Falck; Michal Laniado Schwartzman
Journal:  Circ Res       Date:  2017-03-21       Impact factor: 17.367

Review 10.  Epoxyeicosatrienoic Acids and 20-Hydroxyeicosatetraenoic Acid on Endothelial and Vascular Function.

Authors:  J D Imig
Journal:  Adv Pharmacol       Date:  2016-05-05
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.